Etomidate-containing compositions
AssigneeJanssen Pharmaceutica NV
InventorJean Mesens
Life of this patent
Estimating the term…
Abstract
Improved etomidate-containing compositions for intravenous administration comprising an infusion liquid to which has been added a relatively concentrated solution of an addition salt of etomidate in an ethanolic medium.
Claims12
An etomidate-containing infusion liquid for intravenous administration to provide an anesthetic effect which comprises a physiologically acceptable infusion liquid to which has been added a solution of etomidate hydrochloride or hydrobromide in a medium which contains from 80% to about 99.8% by weight of ethanol to provide an anesthetically effective concentration of at least 0.05 mg/ml of atomidate in the infusion liquid.
An etomidate-containing infusion liquid for intravenous administration to provide an anesthetic effect which comprises a physiologically acceptable infusion liquid to which has been added a solution of etomidate hydrochloride in a medium which contains from 80% to about 99.8% by weight of ethanol to provide an anesthetically effective concentration of at least 0.05 mg/ml of etomidate in the infusion liquid.
An etomidate-containing infusion liquid for intravenous administration to provide an anesthetic effect which comprises a physiologically acceptable infusion liquid to which has been added a solution of etomidate hydrochloride or hydrobromide in absolute ethanol to provide an anesthetically effective concentration of at least 0.05 mg/ml of etomidate in the infusion liquid.
An etomidate-containing infusion liquid for intravenous administration to provide an anesthetic effect which comprises a physiologically acceptable infusion liquid to which has been added a solution of etomidate hydrochloride or hydrobromide in a medium which contains from 80% to about 99.8% by weight of ethanol, to provide a concentration of etomidate base in the infusion liquid of from about 0.05 to about 5 mg per ml.
An etomidate-containing infusion liquid for intravenous administration to provide an anesthetic effect which comprises a physiologically acceptable infusion liquid to which has been added a solution of etomidate hydrochloride in a medium which contains from 80% to about 99.8% by weight of ethanol, to provide a concentration of etomidate base in the infusion liquid of from about 0.05 to about 5 mg per ml.
An etomidate-containing infusion liquid for intravenous administration to provide an anesthetic effect which comprises a physiologically acceptable infusion liquid to which has been added a solution of etomidate hydrochloride in absolute ethanol, to provide a concentration of etomidate base in the infusion liquid of from about 0.05 to about 5 mg per ml.
Dependencies are inferred from the claim text.